Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC-Reference-Cited by-同舟云学术

Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC

Published:2011-10 Issue:2 Volume:218 Page:431-434
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Ahrens Ingo,Habersberger Jonathon,Baumlin Nadège,Qian Hongwei,Smith Belinda K.,Stasch Johannes-Peter,Bode Christoph,Schmidt Harald H.H.W.,Peter Karlheinz

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels;Stasch;J Clin Invest,2006

2. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential;Evgenov;Nat Rev Drug Discov,2006

3. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease;Stasch;Circulation,2011

4. Probing the presence of the ligand-binding haem in cellular nitric oxide receptors;Roy;Br J Pharmacol,2008

5. Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure;Boerrigter;Hypertension,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics for Repurposed Drugs;Drug Repurposing;2024-07-03

2. Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet‐fed rabbits;Pharmacology Research & Perspectives;2021-07-21

3. Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology;Cardiovascular Research;2021-07-16

4. cGMP Signaling in Cardiovascular Diseases;Journal of Cardiovascular Pharmacology;2020-06

5. Inhaled nitric oxide to control platelet hyper-reactivity in patients with acute submassive pulmonary embolism;Nitric Oxide;2020-03